Enjoy complimentary customisation on priority with our Enterprise License!
The electroporation instruments market value is projected to grow by USD 87.59 million at a CAGR of 7.73% during 2021-2025.
This electroporation instruments market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by end-user (pharma and biotech companies, academic and research institutes, and CROs) and geography (North America, Europe, Asia, and ROW). The market report also offers information on several market vendors, including BEX Co. Ltd., Bio Rad Laboratories, Inc, Celetrix LLC, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC., and Thermo Fisher Scientific Inc. among others.
Browse TOC and LoE with selected illustrations and example pages of the Electroporation Instruments Market
According to our research output, there has been a positive impact on the market growth post-COVID-19 era. Key drivers such as the rising demand for monoclonal antibodies are notably supporting the market growth. On the other hand, factors affecting electroporation efficiency have been identified as a market challenge that limits the growth of market vendors. This report offers detailed insights on the challenges to stay prepared for the obstacles in the future, which will help companies analyze and develop growth strategies.
This post-pandemic market report has assessed the shift in consumer behavior and identified and explored the upcoming trends, drivers, and challenges that will have a far-reaching effect on the market growth. Understanding market trends is essential for identifying new business opportunities across segmentations and geographies.
The market forecast report provides insights on complete key vendor profiles and their business strategies to reimage themselves. The profiles covered in the report are as follows:
The electroporation instruments market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The electroporation instruments market forecast report offers insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
31% of the market’s growth will originate from Asia during the forecast period. China and Japan are the key markets for electroporation instruments in Asia.
The report offers an up-to-date analysis of the geographical composition of the market. Asia has been recording a significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. The growing incidence and prevalence of cancer will facilitate the electroporation instruments market growth in Asia over the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample!
The electroporation instruments market share growth by the pharma and biotech companies segment has been significant. This report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2021-2025 and embrace technologies to improve business efficiency.
This report provides an accurate prediction of the contribution of all the segments to the growth of the electroporation instruments market size. The electroporation instruments market offers an exclusive glimpse of actionable market insights on post-COVID-19 impact on each segment.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Electroporation Instruments Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8% |
Market growth 2021-2025 |
$ 87.59 million |
Market structure |
Fragmented |
YoY growth (%) |
6.92 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
Asia at 31% |
Key consumer countries |
US, China, UK, Germany, and Japan |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
BEX Co. Ltd., Bio Rad Laboratories, Inc, Celetrix LLC, Eppendorf AG, Harvard Bioscience Inc., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Mirus Bio LLC., and Thermo Fisher Scientific Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.